Collaborative Management to Improve Diagnosis of Alzheimer Disease

Loading the player ...

Watch this “cinemeducation” video from start to finish for a complete, sequential learning experience OR skip around by clicking on the individual cases listed above to watch each of them in any order that suits your educational needs.


Alzheimer disease (AD) is characterized by declines in memory, language, problem-solving, and other cognitive abilities necessary for performance of daily activities, and is associated with a significant burden for patients, their caregivers, and society. It can be a struggle to diagnose AD, but the benefits of a timely diagnosis for both patients and families cannot be overstated.

Do you have questions about appropriate cognitive, imaging, and biomarker tests for AD you can use in daily practice? Do you sometimes wonder how to talk about AD and diagnostic tests with patients and their families? In this innovative “cinemeducation” format, you will see representative interactions that model best practices. Ready, Set, Action…access this novel educational activity today!

btnArrow CLAIM CME



Andrew E. Budson, MD

Andrew E. Budson, MD

Chief, Cognitive and Behavioral Neurology, VA Boston Healthcare System

Associate Director and Outreach, Recruitment, & Engagement Core Leader, Boston University Alzheimer’s Disease Research Center

Professor of Neurology, Boston University School of Medicine

Lecturer in Neurology, Harvard Medical School

Boston, MA